{
  "id" : "International_Prognostic_Score_for_Asymptomatic_Early_stage_CLL_IPS_E_.v0.1.0",
  "gdl_version" : "2.1",
  "concept" : "gt0001",
  "language" : {
    "original_language" : "ISO_639-1::en"
  },
  "description" : {
    "original_author" : {
      "name" : "Umiah Gohar",
      "email" : "umiah.gohar@cambio.se",
      "organisation" : "Cambio CDS",
      "date" : "2025-10-24"
    },
    "lifecycle_state" : "DRAFTED",
    "details" : {
      "en" : {
        "id" : "en",
        "purpose" : "To calculate and assess the total sum for the IPS-E score.",
        "keywords" : [
          "IPS-E",
          "international ",
          "prognostic ",
          "score ",
          "asymptomatic",
          "early",
          "stage"
        ],
        "use" : "Used in patients diagnosed with early-stage (Rai stages 0-II or Binet stage A) chronic lymphocytic leukemia (CLL) who are currently asymptomatic.\n\nThe score is calculated by adding the points of the idividual variables:\n\nUnmutated IGHV genes : Absent 0 point, Present 0 point\n\nAbsolute lymphocyte count >15×109/L: Absent 0 point, Present 1 point\n\nPalpable lymph nodes: Absent 0 point, Present 1 point\n\nInterpretation:\n\nIPS-E Score = 0 --> Risk for Treatment Need = Low risk\n\nIPS-E  Score = 1--> Risk for Treatment Need = Intermediate risk\n\nIPS-E  Score = 2-3 --> Risk for Treatment Need = High risk\n",
        "misuse" : "Not to be used for advanced disease stages.",
        "copyright" : "© Cambio CDS"
      }
    },
    "other_details" : {
      "en" : "Evaluates prognosis of asymptomatic early-stage chronic lymphocytic leukemia (CLL).",
      "references" : "Condoluci A, Di Bergamo LT, Langerbeins P, Hoechstetter MA, Herling CD, De Paoli L, Delgado J, Rabe KG, Gentile M, Doubek M, Mauro FR, Chiodin G, Mattsson M, Bahlo J, Cutrona G, Kotaskova J, Deambrogi C, Smedby KE, Spina V, Rossi D, et al. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia. Blood. 2020 May 21;135(21):1859-1869. doi: 10.1182/blood.2019003453. PMID: 32142187.\n\nSmolej L, Turcsányi P, Kubová Z, et al. External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score. Br J Haematol. 2021 Apr;193(1):133-137. doi: 10.1111/bjh.17168. Epub 2020 Dec 9. PMID: 33295689.\n\nMorabito F, Tripepi G, Vigna E, et al. Validation of the alternative International Prognostic Score-E (AIPS-E): analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol. Eur J Haematol. 2021 Jun;106(6):831-835. doi: 10.1111/ejh.13622. Epub 2021 Mar 22. PMID: 33599057.\n\nAlshemmari SH, Alsarraf A, Kunhikrishnan A, Pandita R. Evaluation of the CLL-IPI and IPS-E prognostic indices in a young Middle Eastern population with chronic lymphocytic leukemia: a retrospective analysis at the Kuwait Cancer Control Center. Med Princ Pract. 2023;32(3):192-199. doi: 10.1159/000528955. Epub 2023 Jan 18. PMID: 36651635."
    }
  },
  "definition" : {
    "data_bindings" : {
      "gt0002" : {
        "id" : "gt0002",
        "model_id" : "openEHR-EHR-OBSERVATION.international_prognostic_score_for_asymptomatic_early_stage_cll.v0",
        "template_id" : "openEHR-EHR-OBSERVATION.international_prognostic_score_for_asymptomatic_early_stage_cll.v0",
        "type" : "INPUT",
        "elements" : {
          "gt0026" : {
            "id" : "gt0026",
            "path" : "/data[at0001]/events[at0002]/data[at0003]/items[at0019]",
            "data_type" : "DV_ORDINAL",
            "allowed_values" : [
              "0|local::at0022",
              "1|local::at0023"
            ]
          },
          "gt0027" : {
            "id" : "gt0027",
            "path" : "/data[at0001]/events[at0002]/data[at0003]/items[at0020]",
            "data_type" : "DV_ORDINAL",
            "allowed_values" : [
              "0|local::at0024",
              "1|local::at0025"
            ]
          },
          "gt0028" : {
            "id" : "gt0028",
            "path" : "/data[at0001]/events[at0002]/data[at0003]/items[at0021]",
            "data_type" : "DV_ORDINAL",
            "allowed_values" : [
              "0|local::at0026",
              "1|local::at0027"
            ]
          }
        }
      },
      "gt0011" : {
        "id" : "gt0011",
        "model_id" : "openEHR-EHR-EVALUATION.health_risk.v1",
        "template_id" : "openEHR-EHR-EVALUATION.health_risk.v1",
        "type" : "OUTPUT",
        "elements" : {
          "gt0012" : {
            "id" : "gt0012",
            "path" : "/data[at0001]/items[at0003]",
            "data_type" : "DV_TEXT"
          }
        }
      },
      "gt0032" : {
        "id" : "gt0032",
        "model_id" : "openEHR-EHR-OBSERVATION.international_prognostic_score_for_asymptomatic_early_stage_cll.v0",
        "template_id" : "openEHR-EHR-OBSERVATION.international_prognostic_score_for_asymptomatic_early_stage_cll.v0",
        "type" : "OUTPUT",
        "elements" : {
          "gt0033" : {
            "id" : "gt0033",
            "path" : "/data[at0001]/events[at0002]/data[at0003]/items[at0010]",
            "data_type" : "DV_COUNT"
          }
        }
      }
    },
    "rules" : {
      "gt0019" : {
        "id" : "gt0019",
        "priority" : 4,
        "when" : [
          "$gt0026|Unmutated IGHV genes|!=null",
          "$gt0027|Absolute lymphocyte count >15×10^9/L|!=null",
          "$gt0028|Palpable lymph nodes|!=null"
        ],
        "then" : [
          "$gt0033|Total score|.magnitude=$gt0026|Unmutated IGHV genes|.value+$gt0027|Absolute lymphocyte count >15×10^9/L|.value+$gt0028|Palpable lymph nodes|.value"
        ]
      },
      "gt0020" : {
        "id" : "gt0020",
        "priority" : 3,
        "when" : [
          "$gt0033|Total score|==0"
        ],
        "then" : [
          "$gt0012|Risk for Treatment Need|=$gt0023|Low risk|.term"
        ]
      },
      "gt0021" : {
        "id" : "gt0021",
        "priority" : 2,
        "when" : [
          "$gt0033|Total score|==1"
        ],
        "then" : [
          "$gt0012|Risk for Treatment Need|=$gt0024|Intermediate risk|.term"
        ]
      },
      "gt0022" : {
        "id" : "gt0022",
        "priority" : 1,
        "when" : [
          "$gt0033|Total score|>1",
          "$gt0033|Total score|<=3"
        ],
        "then" : [
          "$gt0012|Risk for Treatment Need|=$gt0025|High risk|.term"
        ]
      }
    }
  },
  "ontology" : {
    "term_definitions" : {
      "en" : {
        "id" : "en",
        "terms" : {
          "gt0001" : {
            "id" : "gt0001",
            "text" : "International Prognostic Score for Asymptomatic Early-stage CLL (IPS-E)",
            "description" : "An assessment score used to evaluate prognosis of asymptomatic early-stage chronic lymphocytic leukemia (CLL)."
          },
          "gt0002" : {
            "id" : "gt0002",
            "text" : "openEHR-EHR-OBSERVATION.international_prognostic_score_for_asymptomatic_early_stage_cll.v0"
          },
          "gt0011" : {
            "id" : "gt0011",
            "text" : "openEHR-EHR-EVALUATION.health_risk.v1"
          },
          "gt0012" : {
            "id" : "gt0012",
            "text" : "Risk for Treatment Need"
          },
          "gt0019" : {
            "id" : "gt0019",
            "text" : "Calculate total Score",
            "description" : ""
          },
          "gt0020" : {
            "id" : "gt0020",
            "text" : "Set low risk",
            "description" : ""
          },
          "gt0021" : {
            "id" : "gt0021",
            "text" : "Set intermediate risk",
            "description" : ""
          },
          "gt0022" : {
            "id" : "gt0022",
            "text" : "Set high risk",
            "description" : ""
          },
          "gt0023" : {
            "id" : "gt0023",
            "text" : "Low risk"
          },
          "gt0024" : {
            "id" : "gt0024",
            "text" : "Intermediate risk"
          },
          "gt0025" : {
            "id" : "gt0025",
            "text" : "High risk"
          },
          "gt0026" : {
            "id" : "gt0026",
            "text" : "Unmutated IGHV genes"
          },
          "gt0027" : {
            "id" : "gt0027",
            "text" : "Absolute lymphocyte count >15×10^9/L"
          },
          "gt0028" : {
            "id" : "gt0028",
            "text" : "Palpable lymph nodes"
          },
          "gt0032" : {
            "id" : "gt0032",
            "text" : "openEHR-EHR-OBSERVATION.international_prognostic_score_for_asymptomatic_early_stage_cll.v0"
          },
          "gt0033" : {
            "id" : "gt0033",
            "text" : "Total score"
          }
        }
      }
    }
  }
}